Pacific Biosciences’ New Sequel IIe System Puts Focus on High Read Accuracy
A new version of PacBio's next-generation sequencing platform could lower computing costs for researchers using HiFi reads, the firm's most accurate data type.
ChromoTek is now part of Proteintech
Proteintech, the benchmark in antibodies, announces the acquisition of ChromoTek, a manufacturer of Camelid, single-domain antibodies, also known as nanobodies.
Thermo Fisher Scientific qPCR Consumables Distributorship Update for Singapore Academic Customers
Thermo Fisher Scientific strives to create value for our customers. We are pleased to announce that in April, we will start working with a business partner in your research institution…
Fluidigm and SIgN Establish the First Center of Excellence in Singapore to Advance Imaging Mass Cytometry
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the establishment of a new Center of Excellence (CoE) for…
Fluidigm Introduces AccuLift Laser Capture Microdissection System to Advance Translational and Clinical Pathology Research
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the introduction of the AccuLift™ Laser Capture Microdissection System. Ideal for translational…
Small Sequencer Developer GenapSys Completes $90M Series C Financing
GenapSys has completed a $90 million Series C financing round, with the proceeds set to fund commercialization of a namesake sequencer that according to the company will be the 100…
The Neonatal and Adult Human Testis Defined at the Single-Cell Level.
Spermatogenesis has been intensely studied in rodents but remains poorly understood in humans. Here, we used single-cell RNA sequencing to analyze human testes. Clustering analysis of neonatal testes reveals several…
New technology could detect cancer in blood before symptoms develop
Right now, most diseases are diagnosed after a patient develops symptoms, but a local company wants to change that. It's developed an ultra-sensitive blood protein test that company leaders hope…
Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1
Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, today announced the introduction of a REAP-seq (RNA expression and protein sequencing) protocol for use with the C1™ system. C1…
UK Company to Develop Next Generation CRISPR Gene Editing
The British company Horizon Discovery has obtained a license to develop a CRISPR-based gene editing tool from Rutgers University, USA, with potential applications in cancer and genetic disease.